Literature DB >> 19696479

Gouty arthritis in acute cerebrovascular disease.

Ya-Hui Lin1, Huan-Lin Hsu, Ying-Chih Huang, Meng Lee, Wen-Yi Huang, Yen-Chu Huang, Tsong-Hai Lee, Jiann-Der Lee.   

Abstract

BACKGROUND: Gouty arthritis is a metabolic disorder associated with several medical diseases and is considered as a high-risk factor of acute myocardial infarction and cardiovascular mortality. Since no study has assessed the frequency of gout attack in acute-stroke patients, a retrospective analysis of gouty arthritis in stroke patients was performed to identify the frequency and characteristics of gouty arthritis in hospitalized stroke patients.
METHODS: We reviewed the data of 920 patients admitted to the neurology ward of the Chiayi Chang Gung Memorial Hospital between 2002 and 2005 with ischemic stroke. The frequency of gouty arthritis in these patients was evaluated. The severity of the risk factors was compared between the patients with gout and those without.
RESULTS: The frequency of gouty arthritis in the stroke patients was 6.5%. Most patients had an attack of gout within 9 days of admission. History of gout, uric acid level and hypercholesterolemia were independent risk factors of gout attack during acute stroke. The duration of acute-ward stay was longer in patients with gout than in those without (17.17 vs. 14.01 days, p = 0.016).
CONCLUSIONS: Our retrospective study demonstrated that gout attack is not uncommon in acute-stroke patients and may result in longer duration of acute-ward stay. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19696479     DOI: 10.1159/000235626

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

Review 1.  Inpatient gout: a review.

Authors:  Mark C Fisher; Michael H Pillinger; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

Review 2.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

3.  Increased risk of recurrent gout attacks with hospitalization.

Authors:  Maureen Dubreuil; Tuhina Neogi; Clara A Chen; Hyon K Choi; Christine E Chaisson; David J Hunter; Yuqing Zhang
Journal:  Am J Med       Date:  2013-09-18       Impact factor: 4.965

4.  Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.

Authors:  Masayuki Sakiyama; Hirotaka Matsuo; Seiko Shimizu; Toshinori Chiba; Akiyoshi Nakayama; Yuzo Takada; Takahiro Nakamura; Tappei Takada; Emi Morita; Mariko Naito; Kenji Wakai; Hiroki Inoue; Seishiro Tatsukawa; Junki Sato; Kazumi Shimono; Toshiaki Makino; Takahiro Satoh; Hiroshi Suzuki; Yoshikatsu Kanai; Nobuyuki Hamajima; Yutaka Sakurai; Kimiyoshi Ichida; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Hum Cell       Date:  2013-12-07       Impact factor: 4.174

Review 5.  The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.

Authors:  Robert Eckenstaler; Ralf A Benndorf
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

6.  Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Authors:  Hirotaka Matsuo; Kimiyoshi Ichida; Tappei Takada; Akiyoshi Nakayama; Hiroshi Nakashima; Takahiro Nakamura; Yusuke Kawamura; Yuzo Takada; Ken Yamamoto; Hiroki Inoue; Yuji Oikawa; Mariko Naito; Asahi Hishida; Kenji Wakai; Chisa Okada; Seiko Shimizu; Masayuki Sakiyama; Toshinori Chiba; Hiraku Ogata; Kazuki Niwa; Makoto Hosoyamada; Atsuyoshi Mori; Nobuyuki Hamajima; Hiroshi Suzuki; Yoshikatsu Kanai; Yutaka Sakurai; Tatsuo Hosoya; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.